Composition : Each ml ophthalmic solution contains Bromfenac 0.9mg as Bromfenac sodium INN.
: Bromfenac ophthalmic solution is
indicated for treatment of postoperative inflammation and in patients who have
undergone cataract extraction, prevention of miosis in cataract surgery,
treatment of pseudophakic cystoid macular edema (CME), treatment of external
anterior ocular inflammatory diseases such as blepharitis, conjunctivitis and
and administration : For
the treatment of postoperative inflammation and in patients who have undergone
cataract extraction, one drop of Bromfenac ophthalmic solution should be
applied to the affected eye (s) two times daily beginning 24 hours after
cataract surgery and continuing through the first two weeks of the
postoperative period. Prevention of miosis in cataract surgery: beginning 1
hour prior to surgery, instill bromfenac every 30 minutes. Treatment of
pseudophakic CME: 1 drop 2 times daily for 3 months. Or, as directed by the
in pregnancy and lactation :
There are no adequate and well-controlled studies in pregnant women. This drug
should be used during pregnancy only if the potential benefit to the mother
justifies the potential risk to the fetus. Caution should be exercised when
bromfenac ophthalmic solution is administered to a nursing women.
Packing: 5ml in plastic dropper bottle.
© Copyright Drug International Ltd. 2023 Designed and Developed by ATI Limited.